Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00133770 · ClinicalTrials.gov registry record · Phase 4
Intravenous (IV) Pantoprazole in Erosive Esophagitis
A Phase 4 study of Esophagitis, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00133770: Completed Phase 4 study of Esophagitis, sponsored by Emory University.
NCT00133770 is a Phase 4 study of Esophagitis that has completed, run by Emory University. The registered enrollment target is 20 participants, below the 88-participant average among 5 other Esophagitis trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00133770, a Phase 4 study of Esophagitis, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to examine whether pantoprazole (Protonix) given through continuous intravenous infusion for 72 hours is superior to Protonix given through once a day IV injection in the treatment of erosive esophagitis.
Primary Outcome
the percentage of patients healed from severe esophagitis with IV pantoprazole at 7 days
Conditions Studied
Interventions
- DRUG pantoprazole
Study Locations (1)
Georgia
- Emory University School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-07 |
| Est. Completion | 2007-03 |
| Phase | Phase 4 |
What the finished NCT00133770 record still lists
NCT00133770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 88-participant average among 5 other Esophagitis trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Esophagitis appearing as the primary indexed condition, and to 1 intervention - of which pantoprazole is the first listed.
NCT00133770 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00133770 about?
NCT00133770 is a clinical study titled "Intravenous (IV) Pantoprazole in Erosive Esophagitis". The aim of this study is to examine whether pantoprazole (Protonix) given through continuous intravenous infusion for 72 hours is superior to Protonix given through once a day IV injection in the treatment of erosive esophagitis.
What is the current status of trial NCT00133770?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2004-07. Estimated completion is 2007-03.
What conditions does trial NCT00133770 study?
This clinical trial studies the following conditions: Esophagitis.
What interventions are being tested in trial NCT00133770?
The interventions under investigation include: pantoprazole (DRUG).
Who is sponsoring clinical trial NCT00133770?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00133770 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Domperidone in Treating Patients With Gastrointestinal Disorders
RECRUITING · Phase 3
-
Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
COMPLETED · Phase 1
-
Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment
COMPLETED · NA
-
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
COMPLETED · Phase 2
-
Esophageal Cytology With FISH in Detecting Esophageal Cancer
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia